View the full list of references supporting this article in European Pharmaceutical Review, Issue 02 2026.

References:

1. Moravka KK, et al. Application of moisture activated dry granulation (MADG) process to develop high dose immediate release (IR) formulations. Adv Powder Technol. 2017; 28(4): 1270-1280.

2. Aodah AH, et al. Design, Optimization, and Correlation of In Vitro/In Vivo Disintegration of Novel Fast Orally Disintegrating Tablet of High Dose Metformin Hydrochloride Using Moisture Activated Dry Granulation Process and Quality by Design Approach. Pharmaceutics. 2020; 12: 598.

3. Sharma D, Lanjewar A. Optimization and Evaluation of Ibuprofen Tablets by MADG Method. PharmaTutor. 2018; 6(1): 56-71.

4. Solanki D, et al. Formulation, development and evaluation of paracetamol tablet by moisture activated dry granulation (MADG) process. J Pharm Biol Sci. 2024; 12(1); 60-67.

5. Takasakia H, et al. The importance of binder moisture content in Metformin HCL high-dose formulations prepared by moist aqueous granulation (MAG). Results Pharma Sci. 2015; 5: 1-7.

6. Ullah I, et al. Moisture-activated dry granulation part I: A guide to excipient and equipment selection and formulation development. Pharmaceutical Technology. 2009; 33(11): 62-70.

7. Sapkal NP, et al. Application of a convenient and cost-effective granulation technology for the formulation of tablets using conventional excipients. Asian Journal of Pharmaceutics. 2014; 8: 183-189.

8. Sharma DM, et al. Review on Moisture activated Dry Granulation Process. PharmaTutor. 2017; 5(12): 58-67.